Inventors scoop European awards

Jun 14, 2012
Inventors of a new drug for hepatitis B treatment, a tailor-made hearing aid and improved high speed data transfer were awarded a coveted European Patent Office prize.

Inventors of a new drug for hepatitis B treatment, a tailor-made hearing aid and improved high speed data transfer were awarded a coveted European Patent Office prize here Thursday.

In the research category French scientist Gilles Gosselin, and his co-inventors Jean-Louis Imbach, also of France, and the late US professor Martin L. Bryant won the prize for developing "a highly effective anti-viral drug against hepatitis B".

The new drug shows less cross-resistance with other medications and can thus be used as a first line of treatment, the (EPO) said.

One hundred times more infectious than the that causes AIDS, (HBV) is a particularly persistent disease that chronically affects 350 million people worldwide, despite the availability of vaccines.

Some two billion people have been infected worldwide with HBV.

The EPO's Inventor Award in the category Industry went to Danish scientists Jan Toepholm, Soeren Westermann and Svend Vitting Andersen for developing a tailor-made hearing aid after becoming aware of the drawbacks of traditional hearing-aid design.

In the category Non-European countries the winners were Australians John O' Sullivan, Graham Daniels, Terence Percival, Diethelm Ostry and John Deane, of the Commonwealth Scientific and Industrial Research Organisation, for developing a wireless LAN (local area network) for transfer.

The winner of the European Inventor Award 2012 in the category Lifetime Achievement, German Professor Josef Bille of Heidelberg University, was rewarded for developing a device for .

Bille has filed almost 100 patents in the field of ophthalmology and is a pioneer in the area of laser eye correction.

The Munich-based European Patent Office launched the award in 2006.

Explore further: Study shows more than half of peer-reviewed research articles published during 2007-2012 are now open access

add to favorites email to friend print save as pdf

Related Stories

European office withdraws Nexium patent

Dec 21, 2006

The European Patent Office, answering a generic drug maker's challenge, withdrew a patent on Britain-based AstraZeneca PLC's heartburn treatment, Nexium.

Google signs deal to translate European patents

Nov 30, 2010

(AP) -- Google announced an agreement Tuesday to use its technology to translate patents into 29 European languages, a deal officials hope will smooth the way toward a simplified European patent system after ...

EU gives green light for while-you-wait hepatitis B test

May 18, 2010

An inexpensive new test for the detection of Hepatitis B virus has been given regulatory approval for use in the European Union. The test, developed with support from the Wellcome Trust, delivers accurate results while-you-wait, ...

Recommended for you

Cloning whistle-blower: little change in S. Korea

2 hours ago

The whistle-blower who exposed breakthrough cloning research as a devastating fake says South Korea is still dominated by the values that allowed science fraudster Hwang Woo-suk to become an almost untouchable ...

Color and texture matter most when it comes to tomatoes

Oct 21, 2014

A new study in the Journal of Food Science, published by the Institute of Food Technologists (IFT), evaluated consumers' choice in fresh tomato selection and revealed which characteristics make the red fruit most appealing.

How the lotus got its own administration

Oct 21, 2014

Actually the lotus is a very ordinary plant. Nevertheless, during the Qing dynasty (1644-1911) a complex bureaucratic structure was built up around this plant. The lotus was part of the Imperial Household, ...

What labels on textiles can tell us about society

Oct 21, 2014

Throughout Chinese history, dynastic states used labels on textiles to spread information on the maker, the commissioner, the owner or the date and site of production. Silks produced in state-owned manufacture ...

User comments : 0